SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is seeing significant downward pressure driven by market apprehension surrounding Donald Trump's extended and often incoherent public address, where his discussion of tariffs and Greenland policy raises concerns about global trade stability. Community sentiment is deeply divided, with many expressing alarm over potential economic repercussions while a subset anticipates a swift "buy the dip" recovery from the current volatility.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst significant market volatility, fueled by discussions surrounding former President Trump's public statements on geopolitical issues, including Greenland and proposed tariffs, which are sparking international concern and market reactions. Community chatter is highly polarized, with supporters pointing to a new digital token initiative as a potential short squeeze catalyst, while critics link the former President's rhetoric to broader market instability and question the stock's underlying value.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is highly active amidst intense discussions fueled by geopolitical developments, specifically related to rhetoric from Davos concerning Greenland and potential tariffs impacting European allies. Community sentiment is bifurcated, with many anticipating continued declines from global instability and upcoming interest rate decisions, while a significant portion of traders are actively buying the dip, expecting a customary market rebound despite the contentious headlines.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is a focal point of market discussion after recently upgrading its bid for Warner Bros. Discovery assets to an all-cash offer, a strategic move generating debate about its long-term growth prospects ahead of the upcoming earnings report. Community sentiment is sharply divided, with many seeing the stock as oversold and ripe for a rebound, while others express caution regarding the deal's implications and broader market headwinds.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending dramatically after announcing promising Phase 1 clinical trial results for its oral drug, soquelitinib, treating moderate to severe atopic dermatitis with strong efficacy and a favorable safety profile. The market is actively discussing the drug's potential, especially for patients resistant to current therapies, driving speculation of significant upside and a short squeeze, though some caution against the early trial stage and potential dilution.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending following a significant non-exclusive licensing agreement with Pfizer for its Matrix-M adjuvant technology, widely seen by the community as a validation of its core platform. This development has fueled expectations of further partnerships and a potential short squeeze, with many closely watching how management addresses continued activist investor pressure for enhanced shareholder value.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple (AAPL) is currently experiencing highly polarized community sentiment, with many expressing frustration over its recent price decline, perceived lack of AI innovation, and broader market weakness. However, a strong counter-narrative highlights the stock as deeply oversold with historically low RSI levels, presenting a significant "buy the dip" opportunity ahead of its anticipated strong holiday quarter earnings. Geopolitical tensions and ongoing tariff discussions are further fueling volatility and shaping investor outlook on the tech giant.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is experiencing a surge in attention following a pivotal FDA meeting for its ANKTIVA bladder cancer treatment, where regulators reportedly indicated no requirement for new clinical trials and requested additional data for submission within 30 days. This news has ignited strong community discussion, with investors buzzing about a potential short squeeze and highlighting ANKTIVA's broad therapeutic promise across various cancer indications. The stock's robust performance amid a challenging market is drawing significant interest, as many anticipate further positive developments and substantial long-term growth for this biotech company.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

ProShares Ultra VIX Short-Term Futures ETF ($UVXY) is actively trending as traders weigh potential market volatility driven by discussions surrounding recent geopolitical developments, including international tariffs, and the anticipated Bank of Japan rate hike. The community is sharply divided, with many actively debating short positions on $UVXY due to its inherent decay, while others anticipate a volatility spike, expressing frustration over its subdued movement despite broader market fluctuations.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

Top Wealth Group Holding is trending following news of its strategic acquisition of a luxury wine authentication and trading business, diversifying its market beyond caviar. This has ignited significant discussion among traders, with many anticipating further price movement and highlighting strong volume, while others express concerns about a recent public offering and potential dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should Invesco S&P MidCap Momentum ETF (XMMO) Be on Your Investing Radar?

Court Ruling Lifts Markets: High Beta, Momentum ETFs in Focus

Kyndryl Holdings (KD) shares plunged as much as 12% on Thursday after short-seller Gotham City Research accused the IT services provider of accounting manipulation, claiming the stock is significantly overvalued and could drop by as much as 67% or even to zero.In a <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.gothamcityresearch.com/post/kyndryl-like-the-old-ibm-except-with-an-undisclosed-cost-problem-part-i">report</a> titled ‘Like the old IBM, except with an Undisclosed Cost Problem: Part I,’ Gotham alleged that Kyndryl has misrepresented its financial health by inflating adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) and adjusted free cash flow to create “the illusion of profitability.”Kyndryl, which spun off from IBM in 2021, has benefited from special pricing arrangements with its former parent, according to Gotham.&nbsp;The short-seller highlighted that Kyndryl’s payments to IBM for services totaled around $4 billion in&nbsp;the fiscal&nbsp;year 2021, roughly 25% of its total cost of services. By fiscal&nbsp;year 2023, those payments had declined 60% to $1.4 billion.Gotham argues that&nbsp;cost reductions, rather than operational improvements, are behind Kyndryl’s post-spinoff margin expansion.&nbsp;IBM’s stock&nbsp;traded in the red on Thursday morning, edging lower by 0.5%.The report further warned that these favorable terms are set to expire, predicting a sharp increase in IBM service costs in 2025 and 2026 that could weigh on earnings.CEO Martin Schroeter has downplayed cost pressures in the past, but Gotham estimates Kyndryl faces an additional $1 billion to $2 billion in expenses over the coming years.Another red flag, according to the report, is Kyndryl’s decision to stop disclosing IBM-related costs after fiscal 2023. Gotham suggests this omission may indicate the company is bracing for significantly higher expenses that could challenge its growth narrative.Gotham’s report also raised broader concerns about Kyndryl’s financial reporting. It identified discrepancies in the company’s reported payments to IBM between 2019 and 2023 and flagged a suspiciously stable $1.38 billion in related-party service costs across multiple reporting periods.The company also pointed to Kyndryl’s capitalized costs, which it says are 13.6 times higher than those of industry peers. Adjusted EBITDA, Gotham estimates, would be 61% to 72% lower if Kyndryl applied industry-standard accounting practices.Additionally, the report questioned Kyndryl’s reported cash flows, highlighting an unusually low days sales outstanding (DSO) of 34 days, which is well below the peer average of 80 days, according to the company.Gotham suggested that Kyndryl may be relying on receivables factoring to inflate its cash position artificially.The short-seller also cast doubt on Kyndryl’s “Total Signings” metric, which has increased from $13.5 billion in&nbsp;the fiscal&nbsp;year 2021 to $16.3 billion in 2024, despite declining total revenue.A recently disclosed Critical Audit Matter in Kyndryl’s 2024 10-K added to concerns, with the company’s auditor stating it did not maintain “effective internal control over financial reporting” as of March 31, 2024.Gotham also noted that 50% of Kyndryl’s management compensation is tied to “Adjusted Operating Cash Flow,” a metric the company has not disclosed since 2021.It flagged that insider selling has also increased&nbsp;recently, further fueling concerns.Gotham concluded that Kyndryl’s stock remains “uninvestable” due to these concerns.<figure class="image"><img style="aspect-ratio:1294/302;" src="https://news.stocktwits-cdn.com/Screenshot_2025_03_27_093222_png_d52e5d9a2b.webp" alt="Screenshot 2025-03-27 093222.png" width="1294" height="302"><figcaption>Kyndryl retail sentiment and message volume on March 27 as of 9:35 a.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/KD">Kyndryl’s stock</a>&nbsp;jumped to ‘extremely bullish’ territory.Some investors dismissed the accusations, with one user stating they plan to hold onto their shares.<stembedurl>https://stocktwits.com/tothattila/message/609420502</stembedurl>Another expects a slow recovery through to May, followed by a jump when earnings happen.<stembedurl>https://stocktwits.com/tothattila/message/609431999</stembedurl>The allegations overshadowed Kyndryl’s announcement of an expanded partnership with Google Cloud.&nbsp;The collaboration includes a new Mainframe Modernization with Gen AI Accelerator Program, leveraging Google’s Gemini models to enhance mainframe integration, COBOL-to-Java conversion, and AI training using on-premise data.Kyndryl’s stock has fallen 14% in 2025 but remains up nearly 40% over the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/amd-slides-pre-market-after-jefferies-downgrades-stock-citing-nvidia-dominance-intel-competition-retail-sentiment-sours/chJ22OkRbEd">AMD Slides Pre-Market After Jefferies Downgrades Stock Citing Nvidia Dominance, Intel Competition – Retail Sentiment Sours</a>

Information technology infrastructure provider Kyndryl (USA) booth at Tokyo Rainbow Parade 2023. (Photo by Stanislav Kogiku/SOPA Images/LightRocket via Getty Images)

Kyndryl Stock Sinks After Short-Seller Alleges IBM Deal Masked Billions In Hidden Costs – But Retail Traders Aren’t Buying It

Short-seller Gotham City Research calls Kyndryl ‘uninvestable,’ raising concerns over its financial reporting, cash flows, and insider selling.

Equity

ESAB Corp (ESAB) stock fell about 2.7% over the past week, but Evercore ISI upgraded the stock to ‘In Line’ from ‘Underperform.’According to The Fly, Evercore analyst David Raso set a price target of $120, compared to the earlier price target of $122. The new price target was roughly the same as the stock’s last closing price.The company had forecast 2025 core adjusted earnings between $5.10 and $5.25 per share, compared with Wall Street’s estimate of $5.38 per share last week.Evercore said that while it has trimmed the price, its analysis "suggests enough cushion is baked into ESAB's guide."The analyst said that recent stock weakness, along with ‘a few elements that could break its way to render the guide particularly conservative.’ESAB had forecast total core sales growth to be between flat and a negative 2% in 2025.The company’s fourth-quarter sales had fallen 3% to $671 million.The company, whose products are used in welding and gas control, had said its total sales in the Americas segment had declined 8%, hurt by the strengthening of the U.S. dollar compared to other currencies in the region.The company expects foreign currency-related challenges to dent its sales in 2025 as well.According to FinChat data, ESAB's forward price-to-earnings (PE) ratio is 24.1.The PE ratio gauges a company's profitability. &nbsp;Retail sentiment on Stocktwits remained in the ‘bullish’ (58/100) territory, while retail chatter was ‘normal.’<figure class="image"><img style="aspect-ratio:801/179;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ESAB_Feb_24_6dd3a5fda8.JPG" alt="ESAB’s Sentiment Meter and Message Volume as of 01:17 a.m. ET on Feb. 24, 2025 | Source: Stocktwits" width="801" height="179"><figcaption>ESAB’s Sentiment Meter and Message Volume as of 01:17 a.m. ET on Feb. 24, 2025 | Source: Stocktwits</figcaption></figure>Over the past year, <a href="https://stocktwits.com/symbol/ESAB">ESAB stock </a>has gained 29.8%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/diamondback-energy-q4-earnings-preview-lower-oil-prices-to-dent-bottom-line-retail-remains-extremely-bullish/chdPZaYRxb">Diamondback Energy Q4 Earnings Preview: Lower Oil Prices To Dent Bottom Line, Retail Remains Extremely Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the ESAB company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

ESAB Stock Receives Evercore Upgrade After Recent Selloff, Retail Stays Bullish 

According to The Fly, Evercore analyst David Raso set a price target of $120, compared to the earlier price target of $122.

Light &amp; Wonder Inc. (LNW) stock rose 4.06% in after-hours trading on Tuesday as the company agreed to acquire the charitable gaming assets of Grover Gaming Inc. and G2 Gaming Inc. for $850 million in cash, but retail sentiment slipped.Under the agreement, Light &amp; Wonder will pay a four-year revenue-based earn-out of up to $200 million cash. The purchase price amounts to a 7.7x multiple based on Grover’s 2024 adjusted earnings before interest, taxes, depreciation, and amortization.Grover Charitable Gaming, which has “long-standing” relationships with charitable customers in the states where it operates, reported revenue of $135 million and adjusted EBITDA of $111 million for the year ended December 31, 2024.The transaction is expected to close during the second quarter of 2025. Light &amp; Wonder plans to fund the acquisition with existing cash and incremental debt financing.“Grover Gaming is a leading player in charitable gaming, a category that has experienced significant growth in recent years,” said Matt Wilson, President and CEO of Light &amp; Wonder. “This transaction complements our position as the leading cross-platform global games company by adding another compelling regulated adjacency to our profile.”The deal also complements Light &amp; Wonder’s cross-platform strategy in addition to being highly accretive to “value and earnings with high-single digit” adjusted net operating profit after tax per share accretion in the first full calendar year after the acquisition, &nbsp;the company said. Sentiment on Stocktwits was ‘bearish’ from ‘ bullish’ a day ago. Message volume was in the ‘low’ zone.<figure class="image"><img style="aspect-ratio:1304/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_19_at_12_45_17_PM_11527e6273.png" alt="Screenshot 2025-02-19 at 12.45.17 PM.png" width="1304" height="320"><figcaption>LNW sentiment meter and message volume on Feb 19 as of 2:30 am ET</figcaption></figure>Light &amp; Wonder, a cross-platform global games company, has over 6,000 members.For its next quarterly earnings, the company is expected to post earnings per share of $0.89 on estimated revenue of $799.17 million, according to Stocktwits data.<a href="https://stocktwits.com/symbol/LNW">Light &amp; Wonder stock</a> is up 17% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image. Source: Getty Images

Light & Wonder Stock Jumps After Snapping Up Grover Gaming’s Charitable Assets: Retail Sentiment Lags

The transaction is expected to close during the second quarter of 2025.

Shares of nutrition products company, BellRing Brands Inc., were up 2.89% in after-hours trading on Monday following the company’s better-than-expected first-quarter earnings, with retail sentiment staying strong.BellRing posted $0.58 in earnings per share, beating Wall Street estimates of $0.48. Its revenue stood at $532.9 million, beating estimates of $524.74 million. Its net sales increased by 23.8% compared to the prior year period, driven by a 20.8% increase in volume and a 3% increase in price/mix.For fiscal year 2025, BellRing raised its guidance range for net sales to $2.26 - $2.34 billion and adjusted earnings before interest, taxes, depreciation and amortization (Ebitda) &nbsp;to range between $470-$500 million, translating into net sales and adjusted EBITDA growth of 13%-17% and 7%-14%, respectively, over the fiscal year 2024.BellRing expects fiscal year 2025 capital expenditures of about $7 million.Sentiment on Stocktwits has been ‘extremely bullish’ compared to a week ago. Message volumes climbed to the ‘extremely high’ category.<figure class="image"><img style="aspect-ratio:1294/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_04_at_10_14_33_AM_5d75dd39b9.png" alt="Screenshot 2025-02-04 at 10.14.33 AM.png" width="1294" height="302"><figcaption>BRBR sentiment meter and message volumes on Feb 3</figcaption></figure>“We are pleased with our first quarter performance. Premier Protein consumption accelerated, lifted by distribution gains, strong velocities and incremental promotional activity. The brand achieved new all-time highs for household penetration and total distribution points,” Darcy H. Davenport, president and CEO of BellRing said.“We saw strong margins aided by the timing of marketing spend and non-recurring cost favorability. Our momentum remains high, with the convenient nutrition category continuing to drive robust growth. Our strong start to 2025 gives us greater confidence in the full year and drove our decision to raise our outlook.”During the first quarter, BellRing also repurchased 0.1 million shares for $11 million at an average price of $77.12 per share. As of January 31, 2025, BellRing had $124.1 million remaining under its share repurchase authorization.BellRing’s brands include Premier Protein, a ready-to-drink protein and convenient nutrition brand, and Dymatize, which is a hydrolyzed protein powder supplement.For updates and corrections, email newsroom[at]stocktwits[dot]com

BellRing Brands Stock Up On Q1 Earnings Beat: Retail's Extremely Bullish

BellRing posted $0.58 in earnings per share, beating Wall Street estimates of $0.48. 

Invesco Capital Management LLC - Invesco S&P MidCap Momentum ETF

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

XMMO
Invesco S&P MidCap Momentum ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest XMMO News

XMMOInvesco S&P MidCap Momentum ETF